+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Type, Technology, End User and Country

  • ID: 4841357
  • Report
  • Region: Asia, Asia Pacific
  • 154 pages
  • The Insight Partners
1 of 3

FEATURED COMPANIES

  • Eurofins Scientific
  • Genes2Me LLP
  • Illumina, Inc.
  • LifeCell
  • Medgenome
  • Metropolis India
  • MORE
Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Type, Disease Indication, Technology, and End User
The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 2,570.37 Mn in 2027 from US$ 878.28 in 2018. The market is estimated to grow with a CAGR of 12.8% from 2019-2027.

The key factors responsible for the growth of the market in Asia Pacific are rising burden of genetic diseases among infants, increasing fertility rates and developing healthcare scenario with rising awareness among populace regarding the benefits of prenatal testing. On the other hand, use of digital microfluidics in newborn testing is likely to be a prevalent trend in the future years. Soaring birth rates among developing economies are responsible for fueling global baby boom. However, the rising birth rate also contributes to rising birth defects and infants suffering from several genetic diseases. According to a report published by Bill and Melinda Gates Foundation in 2018, there are almost 250 babies born every minute around the globe. Moreover, according to the Centers for Disease Control and Prevention, the fertility rates for Hispanic women was highest in 2017 among Hispanic women with 67.1 births per 1,000 women.

Asian countries such as India and China also have high fertility rates due to factors such as effects of religion, inadequate supply of family welfare services, poverty, and others. According to the World Bank in 2016, the fertility rates in India were reported to be 2.23 births per women as compared to 1.80 in the United States and 1.62 in China. Moreover, neighboring countries in India, such as Pakistan also has alarming rates of fertility. In 2016, the birth rate in Pakistan was reported to be 3.48 births per woman as per the World Bank data. However, the birthrate in India have successfully reduced its high fertility rate, but still is high as compared to other developed nations. According to the United Nations (UN) report published on June 2019, the fertility rate has reduced to 2.1. Therefore, by 2050 additional 273 million people will be added to India’s population. The increasing number of parturient women across the world are thus likely to create increasing demand for prenatal and newborn genetic tests across the globe leading to the growth of the market.

The Asia Pacific prenatal and newborn genetic testing market, based on the disease indication was segmented into cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria, recurrent pregnancy loss, and Antiphospholipid syndrome, and other diseases. In 2018, Down syndrome segment held the largest share of the market, by disease indication. The highest share of Down syndrome attributes to the high prevalence of this genetic abnormality among fetuses and availability of multiple tests for its screening and diagnostics. However, the cystic fibrosis segment is expected to grow at the fastest rate during the coming year.

Some of the major primary and secondary sources for prenatal and newborn genetic testing included in the report are Food & Drug Administration (FDA), Indian Institutes of Technology (IITs), International Trade Administration (ITA), Japan Society of Obstetrics and Gynecology (JSOG), Council of Scientific and Industrial Research (cSIR), Pakistan Down Syndrome Association (PDSA) and others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Eurofins Scientific
  • Genes2Me LLP
  • Illumina, Inc.
  • LifeCell
  • Medgenome
  • Metropolis India
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Type
1.3.2 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Disease Indication
1.3.3 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Technology
1.3.4 Asia Pacific Prenatal and Newborn Genetic Testing Market - By End User
1.3.5 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Country

2. Asia Pacific Prenatal And Newborn Genetic Testing Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Prenatal And Newborn Genetic Testing- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific - PEST Analysis

5. Asia Pacific Prenatal And Newborn Genetic Testing Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Burden of Genetic Diseases in India
5.1.2 Increasing Fertility Rate
5.2 Key Market Restraints
5.2.1 Risks Associated with Prenatal Testing
5.3 Key Market Opportunities
5.3.1 Development of Policy for Treatment of Rare Diseases
5.4 Future Trends
5.4.1 Digital Microfluidics Poses a New Opportunity Area for the Newborn Screening Market
5.5 Impact Analysis

6. Prenatal And Newborn Genetic Testing Market - Asia Pacific Analysis
6.1 Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Forecasts And Analysis
6.2 Performance of Key Players
6.2.1 F. Hoffmann La-Roche Ltd.
6.2.2 Laboratory Corporation of America Holdings (Sequenom)
6.2.3 PerkinElmer, Inc.
6.3 India Ultrasound Screening Market
6.3.1 Nuchal Translucency
6.3.1.1 Overview
6.3.1.2 Nuchal Translucency Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2 Fetal Nasal Bone
6.3.2.1 Overview
6.3.2.2 Fetal Nasal Bone Market Revenue and Forecast to 2027 (US$ Mn)
6.3.3 Tricuspid Regurgitation
6.3.3.1 Overview
6.3.3.2 Tricuspid Regurgitation (TR) Market Revenue and Forecast to 2027 (US$ Mn)

7. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Type
7.1 Overview
7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Type 2018 & 2027 (%)
7.3 Diagnostic Market
7.3.1 Overview
7.3.2 Diagnostic Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Amniocentesis Market
7.3.3.1 Overview
7.3.3.2 Amniocentesis Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Chorionic Villus Sampling Market
7.3.4.1 Overview
7.3.4.2 Chorionic Villus Sampling Market Revenue and Forecast to 2027 (US$ Mn)
7.3.5 Cytogenetic and Pharmacogenetic Testing Market
7.3.5.1 Overview
7.3.5.2 Cytogenetic and Pharmacogenetic Testing Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Screening Market
7.4.1 Overview
7.4.2 Screening Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Maternal Serum Screening Market
7.4.3.1 Overview
7.4.3.2 Maternal Serum Screening Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Non-Invasive Prenatal Testing Market
7.4.4.1 Overview
7.4.4.2 Non-Invasive Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)

8. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Disease Indication
8.1 Overview
8.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Disease Indication 2018 & 2027 (%)
8.3 Cystic Fibrosis
8.3.1 Overview
8.3.2 Cystic Fibrosis Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Sickle Cell Anemia
8.4.1 Overview
8.4.2 Sickle Cell Anemia Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Down Syndrome
8.5.1 Overview
8.5.2 Downs Syndrome Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Phenylketonuria
8.6.1 Overview
8.6.2 Phenylketonuria Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Recurrent Pregnancy Loss
8.7.1 Overview
8.7.2 Recurrent Pregnancy Loss Market Revenue and Forecast to 2027 (US$ Mn)
8.8 Antiphospholipid Syndrome (APS)
8.8.1 Overview
8.8.2 Antiphospholipid Syndrome Market Revenue and Forecast to 2027 (US$ Mn)
8.9 Other Diseases
8.9.1 Overview
8.9.2 Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Technology
9.1 Overview
9.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by Technology 2018 & 2027 (%)
9.4 Spectrophotometer
9.4.1 Overview
9.4.2 Asia Pacific Spectrophotometer Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Polymerase Chain Reaction Market
9.5.1 Overview
9.5.2 Polymerase Chain Reaction Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Fluorescence in-situ Hybridization Market
9.6.1 Overview
9.6.2 Fluorescence in-situ Hybridization Market Revenue and Forecast to 2027 (US$ Mn)
9.7 Array Comparative Genomic Hybridization Market
9.7.1 Overview
9.7.2 Array Comparative Genomic Hybridization Market Revenue and Forecast to 2027 (US$ Mn)
9.8 Others Market
9.8.1 Overview
9.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

10. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - End User
10.1 Overview
10.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Share by End User 2018 & 2027 (%)
10.3 Hospitals & Clinics
10.3.1 Overview
10.3.2 Asia Pacific Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Diagnostics Centers
10.4.1 Overview
10.4.2 Diagnostics Centers Market Revenue and Forecast to 2027 (US$ Mn)
10.5 Other End Users
10.5.1 Overview
10.5.2 Asia Pacific Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

11. Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 - Geographical Analysis
11.1 Asia Pacific Prenatal And Newborn Genetic Testing Market
11.1.1 Overview
11.1.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.3 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.3.1 Asia Pacific Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.2 Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.4 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.1.5 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.1.6 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)
11.2.1 China Prenatal And Newborn Genetic Testing Market
11.2.1.1 China Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.1.2 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.1.2.1 China Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.1.2.2 China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.1.3 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.1.4 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.1.5 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.2 Japan Prenatal And New born Genetic Testing Market
11.2.2.1 Japan Prenatal And New Born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.2.2 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.2.2.1 Japan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.2.2.2 Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.2.3 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.2.4 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.2.5 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.3 India Prenatal And New born Genetic Testing Market
11.2.3.1 India Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.3.2 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.3.2.1 India Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.3.2.2 India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.3.3 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.3.4 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.3.5 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.4 Pakistan Prenatal And New born Genetic Testing Market
11.2.4.1 Pakistan Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.4.2 Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.4.2.1 Pakistan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.2.2 Pakistan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.3 Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.4.4 Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.4.5 Pakistan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.5 Sri Lanka Prenatal And New born Genetic Testing Market
11.2.5.1 Sri Lanka Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.5.2 Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.5.2.1 Sri Lanka Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.5.2.2 Sri Lanka Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.5.3 Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.5.4 Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.5.5 Sri Lanka Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.6 Bangladesh Prenatal And New born Genetic Testing Market
11.2.6.1 Bangladesh Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.6.2 Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.6.2.1 Bangladesh Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.6.2.2 Bangladesh Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.6.3 Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.6.4 Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.6.5 Bangladesh Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.7 Nepal Prenatal And New born Genetic Testing Market
11.2.7.1 Nepal Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.7.2.1 Nepal Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.7.2.2 Nepal Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.7.3 Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.7.4 Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.7.5 Nepal Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.8 Indonesia Prenatal And Newborn Genetic Testing Market
11.2.8.1 Indonesia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.8.2.1 Indonesia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.8.2.2 Indonesia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.8.3 Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.8.4 Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.8.5 Indonesia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.9 Singapore Prenatal And Newborn Genetic Testing Market
11.2.9.1 Singapore Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.9.2.1 Singapore Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.2.2 Singapore Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.3 Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.9.4 Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.9.5 Singapore Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.10 Malaysia Prenatal And Newborn Genetic Testing Market
11.2.10.1 Malaysia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.10.2.1 Malaysia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.10.2.2 Malaysia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.10.3 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.10.4 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.10.5 Malaysia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.11 Thailand Prenatal And Newborn Genetic Testing Market
11.2.11.1 Thailand Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.11.2.1 Thailand Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.2.2 Thailand Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.3 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.2.11.4 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
11.2.11.5 Thailand Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12. Prenatal And Newborn Genetic Testing Market - Industry Landscape
12.1 Overview
12.2 Comparative Company Analysis
12.3 Growth Strategies Done by the Companies in the Market, (%)
12.4 Organic Developments
12.4.1 Overview
12.5 Inorganic Developments
12.5.1 Overview

13. Prenatal And Newborn Genetic Testing Market-Key Company Profiles
13.1 LifeCell
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Quest Diagnostics Incorporated
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medgenome
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Eurofins Scientific
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Metropolis India
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 SRL Diagnostics
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Information
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sandor Lifesciences Pvt. Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 PerkinElmer, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Natera, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Laboratory Corporation Of America Holdings (Sequenom)
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Genes2Me LLP
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Financial Overview
13.11.4 Product Portfolio
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Illumina, Inc.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Financial Overview
13.12.4 Product Portfolio
13.12.5 SWOT Analysis
13.12.6 Key Developments

14. Appendix
14.1 About the Publishers
14.2 Glossary Of Terms
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • LifeCell
  • Quest Diagnostics Incorporated
  • Medgenome
  • Eurofins Scientific
  • Metropolis India
  • SRL Diagnostics
  • Sandor Lifesciences Pvt Ltd
  • PerkinElmer, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Sequenom)
  • Genes2Me LLP
  • Illumina, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll